Sei Investments Co. Invests $1.06 Million in Billiontoone, Inc. $BLLN

Sei Investments Co. acquired a new stake in Billiontoone, Inc. (NASDAQ:BLLN) in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 13,399 shares of the company’s stock, valued at approximately $1,058,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Rossby Financial LCC acquired a new stake in Billiontoone in the fourth quarter worth approximately $25,000. Wells Fargo & Company MN acquired a new position in shares of Billiontoone during the 4th quarter valued at $76,000. Smartleaf Asset Management LLC bought a new stake in shares of Billiontoone in the 4th quarter worth $80,000. Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Billiontoone in the 4th quarter worth $82,000. Finally, Renaissance Capital LLC acquired a new stake in shares of Billiontoone in the fourth quarter valued at $201,000.

Billiontoone Stock Performance

Shares of BLLN stock opened at $97.45 on Thursday. The company has a market capitalization of $4.48 billion and a price-to-earnings ratio of 139.21. Billiontoone, Inc. has a 1-year low of $61.96 and a 1-year high of $150.44. The company has a current ratio of 11.69, a quick ratio of 11.31 and a debt-to-equity ratio of 0.17. The stock’s fifty day simple moving average is $116.70 and its 200-day simple moving average is $94.55.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.15. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%.The firm had revenue of $109.45 million during the quarter. On average, sell-side analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Oguzhan Atay sold 32,500 shares of the firm’s stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the completion of the sale, the chief executive officer directly owned 20,000 shares in the company, valued at approximately $2,739,000. This trade represents a 61.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $92.86, for a total transaction of $928,600.00. Following the completion of the transaction, the chief technology officer owned 1,000 shares in the company, valued at approximately $92,860. This represents a 90.91% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 213,466 shares of company stock valued at $24,557,044 over the last ninety days. Insiders own 50.22% of the company’s stock.

Wall Street Analyst Weigh In

BLLN has been the subject of several research reports. Wall Street Zen lowered shares of Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Weiss Ratings raised shares of Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research note on Tuesday, June 23rd. BTIG Research decreased their price target on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating on the stock in a research report on Thursday, August 6th. Guggenheim initiated coverage on Billiontoone in a report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target on the stock. Finally, JPMorgan Chase & Co. cut their price objective on Billiontoone from $145.00 to $130.00 and set an “overweight” rating for the company in a research report on Thursday, August 6th. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Billiontoone has a consensus rating of “Moderate Buy” and a consensus price target of $126.71.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.